Table: Santen Pharm -2017/18 parent results

SANTEN PHARMACEUTICAL

09/05/2018 07:00

May 9 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            171.87          156.97                                
                 (+9.5 pct)      (+0.5 pct)                              
  Operating         31.30           31.31                                
                 (+0.0 pct)      (+1.9 pct)                              
  Recurring         31.69           30.38                                
                 (+4.3 pct)      (-0.6 pct)                              
  Net               25.44           25.00                                
                 (+1.7 pct)      (-51.4 pct)                             
  EPS             62.58 yen       60.92 yen                              
  EPS Diluted     62.36 yen       60.70 yen                              
  Ann Div         26.00 yen       26.00 yen      26.00 yen               
  -Q2 Div         13.00 yen       13.00 yen      13.00 yen               
  -Q4 Div         13.00 yen       13.00 yen      13.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T